المؤلفون: Gornik HL, Aronow HD, Goodney PP, Arya S, Brewster LP, Byrd L, Chandra V, Drachman DE, Eaves JM, Ehrman JK, Evans JN, Getchius TSD, Gutiérrez JA, Hawkins BM, Hess CN, Ho KJ, Jones WS, Kim ESH, Kinlay S, Kirksey L, Kohlman-Trigoboff D, Long CA, Pollak AW, Sabri SS, Sadwin LB, Secemsky EA, Serhal M, Shishehbor MH, Treat-Jacobson D, Wilkins LR

مؤلفون مشاركون: Writing Committee Members

المصدر: Journal of the American College of Cardiology [J Am Coll Cardiol] 2024 Jun 18; Vol. 83 (24), pp. 2497-2604. Date of Electronic Publication: 2024 May 14.

نوع المنشور: Journal Article; Practice Guideline

بيانات الدورية: Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8301365 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-3597 (Electronic) Linking ISSN: 07351097 NLM ISO Abbreviation: J Am Coll Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Peripheral Arterial Disease*/therapy , Peripheral Arterial Disease*/diagnosis , Lower Extremity*/blood supply , American Heart Association*, Humans ; United States ; Cardiology/standards ; Societies, Medical/standards

المؤلفون: Gornik HL, Aronow HD, Goodney PP, Arya S, Brewster LP; VESS representative., Byrd L; Layperson or patient representative., Chandra V; SVS representative., Drachman DE, Eaves JM, Ehrman JK; AACVPR representative., Evans JN; APMA representative., Getchius TSD, Gutiérrez JA, Hawkins BM, Hess CN, Ho KJ, Jones WS; AHA/ACC Joint Committee on Clinical Practice Guidelines liaison., Kim ESH; SVM representative., Kinlay S, Kirksey L; ABC representative., Kohlman-Trigoboff D, Long CA, Pollak AW, Sabri SS, Sadwin LB; Layperson or patient representative., Secemsky EA, Serhal M, Shishehbor MH; SCAI representative., Treat-Jacobson D; SVN representative., Wilkins LR; SIR representative.

المصدر: Circulation [Circulation] 2024 Jun 11; Vol. 149 (24), pp. e1313-e1410. Date of Electronic Publication: 2024 May 14.

نوع المنشور: Journal Article; Practice Guideline; Review

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4539 (Electronic) Linking ISSN: 00097322 NLM ISO Abbreviation: Circulation Subsets: MEDLINE

مواضيع طبية MeSH: Peripheral Arterial Disease*/therapy , Peripheral Arterial Disease*/diagnosis , Lower Extremity*/blood supply , American Heart Association*, Humans ; United States ; Cardiology/standards

المؤلفون: Muntner P; Department of Epidemiology, University of Alabama at Birmingham, 1665 University Boulevard, Birmingham, AL, 35294, USA., Ghazi L; Department of Epidemiology, University of Alabama at Birmingham, 1665 University Boulevard, Birmingham, AL, 35294, USA. lghazi@uab.edu., Jones J; Center for Observational Research, Amgen Inc., Thousand Oaks, CA, USA., Dhalwani N; Center for Observational Research, Amgen Inc., Thousand Oaks, CA, USA., Poudel B; Department of Epidemiology, University of Alabama at Birmingham, 1665 University Boulevard, Birmingham, AL, 35294, USA., Wen Y; Department of Epidemiology, University of Alabama at Birmingham, 1665 University Boulevard, Birmingham, AL, 35294, USA., Chen L; Department of Epidemiology, University of Alabama at Birmingham, 1665 University Boulevard, Birmingham, AL, 35294, USA., Wang Z; Department of Epidemiology, University of Alabama at Birmingham, 1665 University Boulevard, Birmingham, AL, 35294, USA., Bittner V; Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Kalich B; Amgen Inc., Thousand Oaks, CA, USA., Farkouh ME; Department of Medicine, Cedar-Sinai School of Medicine, Los Angeles, CA, USA., Woodward M; The George Institute for Global Health, School of Public Health, Imperial College London, London, UK.; The George Institute for Global Health, University of New South Wales, Sydney, Australia., Colantonio LD; Department of Epidemiology, University of Alabama at Birmingham, 1665 University Boulevard, Birmingham, AL, 35294, USA., Rosenson RS; Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA.

المصدر: Advances in therapy [Adv Ther] 2024 Jun; Vol. 41 (6), pp. 2399-2413. Date of Electronic Publication: 2024 Apr 30.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE

مواضيع طبية MeSH: Ezetimibe*/therapeutic use , PCSK9 Inhibitors* , Anticholesteremic Agents*/therapeutic use , Medication Adherence*/statistics & numerical data, Humans ; Male ; Middle Aged ; Female ; Aged ; Adult ; Antibodies, Monoclonal/therapeutic use ; United States ; Hypercholesterolemia/drug therapy ; Proprotein Convertase 9

المؤلفون: Vadhariya A; Department of Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy, Houston, TX, USA., Sharma M; Department of Pharmacy Administration, School of Pharmacy the University of Mississippi, University, MS, USA., Abughosh SM; Department of Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy, Houston, TX, USA., Birtcher KK; University of Houston College of Pharmacy, Houston, TX, USA., Chen H; Department of Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy, Houston, TX, USA., Mohan A; Department of Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy, Houston, TX, USA., Johnson ML; Department of Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy, Houston, TX, USA.

المصدر: Journal of pharmacy practice [J Pharm Pract] 2024 Feb; Vol. 37 (1), pp. 123-131. Date of Electronic Publication: 2022 Oct 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 8900945 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-1937 (Electronic) Linking ISSN: 08971900 NLM ISO Abbreviation: J Pharm Pract Subsets: MEDLINE

مواضيع طبية MeSH: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Cardiovascular Diseases*/drug therapy, Humans ; United States/epidemiology ; Aged ; Retrospective Studies ; Lipids ; Managed Care Programs

المؤلفون: Delabays B; Department of Medicine, Division of Internal Medicine, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, Lausanne 1011, Switzerland., de La Harpe R; Department of Medicine, Division of Internal Medicine, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, Lausanne 1011, Switzerland., Vollenweider P; Department of Medicine, Division of Internal Medicine, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, Lausanne 1011, Switzerland., Fournier S; Heart and Vessel Department, Division of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, Lausanne 1011, Switzerland., Müller O; Heart and Vessel Department, Division of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, Lausanne 1011, Switzerland., Strambo D; Department of Clinical Neurosciences, Division of Neurology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, Lausanne 1011, Switzerland., Graham I; School of Medicine, Trinity College Dublin, The University of Dublin, College Green, Dublin 2 D02 PN40, Ireland., Visseren FLJ; Department of Vascular Medicine, University Medical Center Utrecht and Utrecht University, Heidelberglaan 100, Utrecht 3584 CX, Netherlands., Nanchen D; Center for Primary Care and Public Health (Unisanté), University of Lausanne, Rue du Bugnon 44, Lausanne 1011, Switzerland., Marques-Vidal P; Department of Medicine, Division of Internal Medicine, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, Lausanne 1011, Switzerland., Vaucher J; Department of Medicine, Division of Internal Medicine, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, Lausanne 1011, Switzerland.

المصدر: European journal of preventive cardiology [Eur J Prev Cardiol] 2023 Nov 30; Vol. 30 (17), pp. 1856-1864.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101564430 Publication Model: Print Cited Medium: Internet ISSN: 2047-4881 (Electronic) Linking ISSN: 20474873 NLM ISO Abbreviation: Eur J Prev Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Cardiovascular Diseases*/diagnosis , Cardiovascular Diseases*/epidemiology , Cardiovascular Diseases*/prevention & control , Hydroxymethylglutaryl-CoA Reductase Inhibitors* , Cardiology* , Atherosclerosis*/prevention & control, Male ; Humans ; Female ; United States/epidemiology ; Aged ; Aged, 80 and over ; Primary Prevention ; Lipids ; Risk Factors ; Risk Assessment

المؤلفون: Vallejo-Vaz AJ; School of Public Health, Imperial College London, London, UK.; Department of Medicine, Faculty of Medicine, University of Seville, Seville, Spain.; Clinical Epidemiology and Vascular Risk, Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/Universidad de Sevilla/CSIC, Seville, Spain., Bray S; Global Biostatistical Science, Amgen Ltd, Cambridge, UK., Villa G; Global Health Economics, Amgen Europe (GmbH), Rotkreuz, Switzerland., Brandts J; Imperial Centre for Cardiovascular Disease Prevention Imperial Clinical Trials Unit, Department of Primary Care and Public Health, School of Public Health, Imperial College London, Stadium House, 68 Wood Lane, London, W12 7RH, UK.; Department of Internal Medicine I, University Hospital RWTH Aachen, Aachen, Germany., Kiru G; Imperial Clinical Trials Unit, Imperial College London, London, UK., Murphy J; Imperial Clinical Trials Unit, Imperial College London, London, UK., Banach M; Department of Hypertension, Medical University of Łódź, Łódź, Poland.; Polish Mother's Memorial Hospital-Research Institute (PMMHRI), Łódź, Poland.; Cardiovascular Research Centre, University of Zielona Góra, Zielona Góra, Poland., De Servi S; IRCCS MultiMedica, Milan, Italy., Gaita D; Institutul de Boli Cardiovasculare, Fundatia Cardioprevent, Victor Babeş University of Medicine and Pharmacy, Timisoara, Romania., Gouni-Berthold I; Centre for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Kees Hovingh G; Department of Vascular Medicine, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, Netherlands., Jozwiak JJ; Department of Family Medicine and Public Health, Faculty of Medicine, University of Opole, Opole, Poland., Jukema JW; Leiden University Medical Center, Leiden, Netherlands., Gabor Kiss R; Hungarian Army Medical Center, Budapest, Hungary., Kownator S; Centre Cardiologique et Vasculaire, Thionville, France., Iversen HK; Department of Neurology, Stroke Centre Rigshospitalet, Copenhagen, Rigshospitalet, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Maher V; Trinity College Dublin, Dublin, Ireland.; Advanced Lipid Management and Research Centre, Tallaght University Hospital, Dublin, Ireland., Masana L; Universitat Rovira I Virgili, IISPV, CIBERDEM, Saint Joan University Hospital, Reus, Spain., Parkhomenko A; Emergency Cardiology Department, Institute of Cardiology, Kiev, Ukraine., Peeters A; Cliniques Universitaires Saint Luc, Brussels, Belgium., Clifford P; Imperial Hospitals NHS Trust (Hammersmith Campus), London, UK., Raslova K; Slovak Medical University, Bratislava, Slovakia., Siostrzonek P; Krankenhaus Barmherzige Schwestern Linz, Linz, Austria., Romeo S; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.; Clinical Nutrition, Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.; Cardiology Department, Sahlgrenska University Hospital, Gothenburg, Sweden., Tousoulis D; National and Kapodistrian University of Athens, Medical School, Athens, Greece., Vlachopoulos C; National and Kapodistrian University of Athens, Medical School, Athens, Greece., Vrablik M; 1st Medical Faculty, Charles University and General University Hospital, Prague, Czech Republic., Catapano AL; IRCCS MultiMedica, Milan, Italy., Poulter NR; Imperial Clinical Trials Unit, Imperial College London, London, UK., Ray KK; Imperial Centre for Cardiovascular Disease Prevention Imperial Clinical Trials Unit, Department of Primary Care and Public Health, School of Public Health, Imperial College London, Stadium House, 68 Wood Lane, London, W12 7RH, UK. k.ray@imperial.ac.uk.; Imperial Clinical Trials Unit, Imperial College London, London, UK. k.ray@imperial.ac.uk.

مؤلفون مشاركون: DA VINCI Study Investigators

المصدر: Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2023 Oct; Vol. 37 (5), pp. 941-953. Date of Electronic Publication: 2022 May 14.

نوع المنشور: Observational Study; Journal Article

بيانات الدورية: Publisher: Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy Country of Publication: United States NLM ID: 8712220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7241 (Electronic) Linking ISSN: 09203206 NLM ISO Abbreviation: Cardiovasc Drugs Ther Subsets: MEDLINE

مواضيع طبية MeSH: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Atherosclerosis*/diagnosis , Atherosclerosis*/drug therapy , Atherosclerosis*/epidemiology , Cardiovascular Diseases*/diagnosis , Cardiovascular Diseases*/epidemiology , Cardiovascular Diseases*/prevention & control, United States/epidemiology ; Humans ; Cholesterol, LDL ; Cross-Sectional Studies ; Risk Reduction Behavior ; Risk Factors

المؤلفون: Canonico ME; CPC Clinical Research, 2115 N Scranton Street #2040, Aurora, CO, 80045-7120, USA. marioenrico.canonico@cpcmed.org.; Division of Cardiology, Department of Medicine, University of Colorado, 12631 East 17th Avenue, B130, Aurora, CO, 80045, USA. marioenrico.canonico@cpcmed.org., Hess CN; CPC Clinical Research, 2115 N Scranton Street #2040, Aurora, CO, 80045-7120, USA.; Division of Cardiology, Department of Medicine, University of Colorado, 12631 East 17th Avenue, B130, Aurora, CO, 80045, USA., Cannon CP; CPC Clinical Research, 2115 N Scranton Street #2040, Aurora, CO, 80045-7120, USA.; Division of Cardiovascular Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA.

المصدر: Current atherosclerosis reports [Curr Atheroscler Rep] 2023 Jul; Vol. 25 (7), pp. 381-389. Date of Electronic Publication: 2023 May 24.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 100897685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6242 (Electronic) Linking ISSN: 15233804 NLM ISO Abbreviation: Curr Atheroscler Rep Subsets: MEDLINE

مواضيع طبية MeSH: Acute Coronary Syndrome*/drug therapy , Anticholesteremic Agents*/therapeutic use , Anticholesteremic Agents*/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use, United States ; Humans ; Proprotein Convertase 9 ; PCSK9 Inhibitors ; Cholesterol, LDL ; Subtilisin/therapeutic use ; Proprotein Convertases/therapeutic use ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal/pharmacology

المؤلفون: Jarujumrus I; Pharmacy division, Phramongkutklao hospital, 315 Ratchawithi Rd., Thung Phaya Thai, Ratchathewi District, Bangkok, 10400, Thailand., Taychakhoonavudh S; Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Phayathai Rd, Wang Mai, Pathum Wan District, Bangkok, 10330, Thailand. suthira.t@chula.ac.th.

المصدر: BMC health services research [BMC Health Serv Res] 2023 May 24; Vol. 23 (1), pp. 533. Date of Electronic Publication: 2023 May 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963 (Electronic) Linking ISSN: 14726963 NLM ISO Abbreviation: BMC Health Serv Res Subsets: MEDLINE

مواضيع طبية MeSH: Prescription Drugs* , Diabetes Mellitus, Type 2*/drug therapy, United States ; Humans ; Thailand ; Medication Adherence ; Policy ; Drug Prescriptions ; Hospitals, Military

المؤلفون: Cuchel M; Division of Translational Medicine and Human Genetics, Department of Medicine Perelman School of Medicine at the University of Pennsylvania Philadelphia PA., Lee PC; Division of Translational Medicine and Human Genetics, Department of Medicine Perelman School of Medicine at the University of Pennsylvania Philadelphia PA., Hudgins LC; The Rogosin Institute/Weill Cornell Medical College New York NY., Duell PB; Center for Preventive Cardiology, Knight Cardiovascular Institute, and Division of Endocrinology, Diabetes, and Clinical Nutrition, Department of Medicine Oregon Health and Science University Portland OR., Ahmad Z; Division of Endocrinology, Department of Internal Medicine UT Southwestern Medical Center Dallas TX., Baum SJ; Flourish Research Boca Raton FL., Linton MF; Division of Cardiovascular Medicine, Department of Medicine Vanderbilt University Medical Center Nashville TN., de Ferranti SD; Department of Cardiology Boston Children Hospital Boston MA., Ballantyne CM; Baylor College of Medicine Houston TX., Larry JA; Ohio State University Wexner Medical Center Columbus OH., Hemphill LC; Massachusetts General Hospital Boston MA., Kindt I; DEARhealth INC. Los Angeles CA., Gidding SS; Geisinger Danville PA., Martin SS; Division of Cardiology, Department of Medicine, Ciccarone Center for the Prevention of Cardiovascular Disease Johns Hopkins University School of Medicine Baltimore MD., Moriarty PM; University of Kansas Medical Center Kansas City KS., Thompson PP; Hartford Hospital Hartford CT., Underberg JA; NYU Langone Medical Center New York NY., Guyton JR; Division of Endocrinology, Metabolism, and Nutrition, Department of Medicine Duke University Medical Center Durham NC., Andersen RL; Lancaster General Health/Penn Medicine Lancaster PA., Whellan DJ; Thomas Jefferson University Philadelphia PA., Benuck I; Department of Pediatrics Feinberg School of Medicine Chicago IL., Kane JP; UC San Francisco San Francisco CA., Myers K; Family Heart Foundation Pasadena CA., Howard W; Atomo Inc. Austin TX., Staszak D; Atomo Inc. Austin TX., Jamison A; Family Heart Foundation Pasadena CA., Card MC; Family Heart Foundation Pasadena CA., Bourbon M; Unidade de I&D, Grupo de Investigação Cardiovascular, Departamento de Promoção da Saúde e Prevenção de Doenças Não Transmissíveis Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa AND BioISI-Biosystems and Integrative Sciences Institute, Faculdade de Ciências, Universidade de Lisboa Lisboa Portugal., Chora JR; Unidade de I&D, Grupo de Investigação Cardiovascular, Departamento de Promoção da Saúde e Prevenção de Doenças Não Transmissíveis Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa AND BioISI-Biosystems and Integrative Sciences Institute, Faculdade de Ciências, Universidade de Lisboa Lisboa Portugal., Rader DJ; Division of Translational Medicine and Human Genetics, Department of Medicine Perelman School of Medicine at the University of Pennsylvania Philadelphia PA., Knowles JW; Family Heart Foundation Pasadena CA.; Division of Cardiovascular Medicine, Department of Medicine Cardiovascular Institute Stanford CA.; Stanford Diabetes Research Center Stanford CA.; Stanford Prevention Research Center Stanford CA., Wilemon K; Family Heart Foundation Pasadena CA., McGowan MP; Family Heart Foundation Pasadena CA.; Department of Medicine Section of Cardiovascular Medicine, Dartmouth-Hitchcock Medical Center Lebanon NH.

المصدر: Journal of the American Heart Association [J Am Heart Assoc] 2023 May 02; Vol. 12 (9), pp. e029175. Date of Electronic Publication: 2023 Apr 29.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE

مواضيع طبية MeSH: Homozygous Familial Hypercholesterolemia* , Cardiovascular Diseases*/drug therapy , Hyperlipoproteinemia Type II*/diagnosis , Hyperlipoproteinemia Type II*/epidemiology , Hyperlipoproteinemia Type II*/genetics , Atherosclerosis*/diagnosis , Atherosclerosis*/epidemiology , Atherosclerosis*/genetics , Anticholesteremic Agents*/therapeutic use, United States/epidemiology ; Humans ; Cholesterol, LDL ; Registries ; Homozygote

المؤلفون: Shen M; Department of Internal Medicine Yale School of Medicine New Haven CT., Aghajani Nargesi A; Department of Internal Medicine Yale School of Medicine New Haven CT.; Heart and Vascular Center Brigham and Women's Hospital, Harvard Medical School Boston MA., Nasir K; Division for Cardiovascular Prevention and Wellness, Department of Cardiology Houston Methodist DeBakey Heart and Vascular Center Houston TX.; Center for Outcomes Research Houston Methodist Houston TX., Bhatt DL; Heart and Vascular Center Brigham and Women's Hospital, Harvard Medical School Boston MA., Khera R; Section of Cardiovascular Medicine, Department of Internal Medicine Yale School of Medicine New Haven CT.; Center for Outcomes Research and Evaluation Yale-New Haven Hospital New Haven CT.

المصدر: Journal of the American Heart Association [J Am Heart Assoc] 2022 Sep 20; Vol. 11 (18), pp. e026075. Date of Electronic Publication: 2022 Sep 14.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE

مواضيع طبية MeSH: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use, Adult ; Ezetimibe/therapeutic use ; Humans ; Nutrition Surveys ; Proprotein Convertases ; Subtilisins ; United States/epidemiology